ResearchPDF Available

Effect of a new topical treatment on androgenetic hair loss in men

May 2018

DOI:10.13140/RG.2.2.27547.98086

Authors:

Hans van Montfort

Maastricht University

Hair loss is a frequent and distressing condition for both man and woman. The aim of our study was to evaluate a new topical product named REP884. This combination of natural ingredients was composed for one member of our family with the combination of androgenetic and telogen hair loss. Because of the reactions we decided to test it on more subjects. We did see an overall increase of the Hair Mass Index with the cross section trichometer of average 61 %. The hair line moved forward and also in the self-assessment the scores improved. There were no side effects. REP884 seems to be a safe and effective treatment for both hair loss as to improve the quality of the hair.

No caption available

…

No caption available

…

Figures - uploaded by Hans van Montfort

Content may be subject to copyright.

Content uploaded by Hans van Montfort

Content may be subject to copyright.

Content uploaded by Hans van Montfort

Content may be subject to copyright.

Content uploaded by Hans van Montfort

Content may be subject to copyright.

Content uploaded by Hans van Montfort

Content may be subject to copyright.

A preview of the PDF is not available

ResearchGate has not been able to resolve any citations for this publication.

ResearchGate has not been able to resolve any references for this publication.

Article

Full-text available

Effect of a new topical treatment on androgenetic and telogen hair loss in women

February 2020

Hair loss is a frequent and distressing condition for both man and woman. The aim of our study was to evaluate a new topical product named REP884. This combination of natural ingredients was composed for one member of our family with the combination of androgenetic and telogen hair loss. Because of the reactions we decided to test it on more subjects. We did see an overall increase of the Hair ... [Show full abstract] Mass Index with the cross section trichometer of average 61 %. The hair line moved forward and also in the self-assessment the scores improved. There were no side effects. REP884 seems to be a safe and effective treatment for both hair loss as to improve the quality of the hair.

Presentation

Full-text available

Function tests of a hair growth serum

September 2022

Hans van Montfort

Our Company is collaborating with Cutia Therapeutics based in Shanghai, China, a pharmaceutical Company. Like in Europe an anti-hair-loss serum or hair growth serum is on the border of a cosmetic product and a medication. To see if our product fits for the Chinese market they performed 2 studies. One performed by a third party and one on own employees or their family. In the pdf you can find the ... [Show full abstract] results. 100% satisfaction and 55% decrease of hair loss on mild alopecia androgenetica. Also, density and hair thickness improved. The scalp environment improved as well. In the pictures you will see the results both on top of the head as well as at the hairline temples. I’m proud that all my claims about my formula are confirmed.

Article

Male Androgenetic Alopecia : Response To Finasteride

January 2004 · Indian Journal of Dermatology

Androgenetic alopecia (AGA) is one of the most common causes of hair loss in genetically predisposed men and women. We studied the therapeutic efficacy and safety of oral finasteride in male patients with AGA. A total of 40 male AGA patients, 18-35 years of age, wad enrolled in the study for a period of 9 months. Oral finasteride, 1mg/day, was started and the drug efficacy was assessed on the ... [Show full abstract] basis of pre- and post-treatment clinical photographs, trichogram, hair pull test and self assessment of hair re-growth by the investigators. Routine hematological and bio-chemical investigations and a questionnaire related to sexual disturbances were carried out to assess the safety profile of the drug at each follow-up visit every three months. Improvement in hair growth was observed by comparing the paired pre- and post-treatment global photographs (p<0.05), decreased hair shedding by the patientsâ€ self assessment (p<0.05), hair pull test evaluation (p<0.001) and increase in anagen-telogen hair ratio (p<0.001) with the trichogram, as early as 3 months of finasteride therapy with maximum benefit in the mid-area followed by vertex and frontal areas. No significant side effect related to the drug was observed. It is concluded that oral finasteride is a relatively safe, well tolerated and efficacious drug for AGA in Males.

Article

Treating young men with hair loss

May 1989 · The BMJ

A B Shrank